What is Medtronic's D&A?

Medtronic (MDT) reported D&A of $716M in Q1 2026.

How has Medtronic's D&A changed year-over-year?

Medtronic's D&A decreased by 14.8% year-over-year, from $840M to $716M.

What is the long-term trend for Medtronic's D&A?

Over 4 years (2022 to 2026), Medtronic's D&A has grown at a 2.2% compound annual growth rate (CAGR), from $2.71B to $2.96B.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Medtronic MDT D&A

D&A at other companies

TFX

TeleflexTFX

$19.85M+52.3%

Johnson & JohnsonJNJ

$2B+13.1%

ArtivionAORT

$6.34M+16.4%

CONMEDCNMD

$4.17M-1.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

Boston ScientificBSX

$351M+8.0%

Segments

By segment

See full

Neuroscience$85M+18.1%

Cardiovascular$67M+15.5%

Medical Surgical$56M+5.7%

Diabetes$32M+6.7%

Other operating segment$0—

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$100.14B-9.3%

Enterprise value$127.4B-7.6%

P/E20.9×-2.8×

P/S2.8×-0.5×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's D&A?: Medtronic (MDT) reported D&A of $716M in Q1 2026.
How has Medtronic's D&A changed year-over-year?: Medtronic's D&A decreased by 14.8% year-over-year, from $840M to $716M.
What is the long-term trend for Medtronic's D&A?: Over 4 years (2022 to 2026), Medtronic's D&A has grown at a 2.2% compound annual growth rate (CAGR), from $2.71B to $2.96B.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.